Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 17/03/20031 min de lecture
Determination of Regulatory Review Period for Purposes of Patent Extension; VITREON; Amendment
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is amending its determination regarding the regulatory review period for purposes of patent extension for VITREON that appeared in the Federal Register of December 17, 1998 (63 FR 69633). FDA is amending the document because the agency agrees with the information provided in a request from the applicant for revision of the regulatory review period.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →